The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TIGER-3: A phase 3 multinational open-label randomized study of rociletinib vs investigator-choice chemotherapy in patients (pts) with epidermal growth factor receptor mutant-positive (EGFRm) non-small cell lung cancer (NSCLC) progressing on prior EGFR tyrosine kinase inhibitor (TKI) therapy and doublet chemotherapy.
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech
 
Sanjay Popat
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD
 
Silvia Novello
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Roche
 
Harry J.M. Groen
Research Funding - GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
 
Maurice Perol
Honoraria - Clovis Oncology
Consulting or Advisory Role - Clovis Oncology
 
Enriqueta Felip
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche
 
Frank Griesinger
Honoraria - Boehringer Ingelheim; Celgene; Clovis Oncology; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Clovis Oncology; MSD; Novartis; Pfizer; Roche
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim
Research Funding - Adaptimmune; ARIAD; Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Eisai; Gilead Sciences; GlaxoSmithKline; Novartis; Pfizer; Pfizer; Xcovery
 
Jong-Seok Lee
No Relationships to Disclose
 
Egbert F. Smit
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Roche/Genentech (Inst)
 
Collin M. Blakely
No Relationships to Disclose
 
Wallace L. Akerley
Research Funding - Biodesix; Bristol-Myers Squibb; Clovis Oncology; Genentech; Novartis
 
Young-Chul Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Hanmi; Lilly; Roche
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - AstraZeneca; Genoptix; Heat Biologics; Pfizer
Speakers' Bureau - Genentech; Novartis
 
Raffaele Califano
Honoraria - Clovis Oncology
Consulting or Advisory Role - Clovis Oncology
 
Richard Delmar Hall
Honoraria - Clovis Oncology
Consulting or Advisory Role - Clovis Oncology
 
Panayiotis Georgiou
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Jeffrey D. Isaacson
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Tony Golsorkhi
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Heather A. Wakelee
Honoraria - ACEA Biosciences; Biocon; Helsinn Therapeutics; Peregrine Pharmaceuticals; Pfizer
Consulting or Advisory Role - ACEA Biosciences; Helsinn Therapeutics; Peregrine Pharmaceuticals; Pfizer
Research Funding - Agennix (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - ACEA Biosciences; Clovis Oncology; Novartis; Pfizer